Shortcut to Body Shortcut to main menu

Current status of Industrial Clusters

  • Home
  • Investment Projects
  • Current status of Industrial Clusters
Daegu-Gyeongbuk High-tech Medical Complex

■ Overview

  • Location: within the Daegu Innovation City in Sinseo-dong, Dong-gu, Daegu City
  • Area: 1030,000㎡ (innovation city 4216,000㎡)
  • Project period: 2009~2038 (Construction: 2009~2013)
  • Total budget: KRW 4.6 trillion (national expense KRW 1.1 trillion, municipal expense KRW 0.9 trillion and private investment KRW 2.6 trillion)
  • Land for sales :Jun. 29, 2012~
  • Facilities
    - Government facilities: New Drug Development Support Center, High-tech Medical Equipment Development Support Center, Lab Animal Center, Clinical Drug Manufacturing Center
    - Regional and private facilities: Communication Center (Daegu City), High-tech Clinical Trial Center, research institutions and laboratory enterprises, venture centers etc.

■ Background

  • Dec. 16, 2009: Designation and announcement of the high-tech medical complex
  • Jan. 27, 2010: Finalization of the plan to establish the high-tech medical complex
  • Oct. 27, 2011: Began construction of government and regional facilities
  • Dec. 2013: Completed the construction of the complex

■ Bird’s Eye View

■ Design of High-tech Medical Complex

■ Facilities

Name of the Facility Agents Site area(㎡) Total floor area(㎡) Functions
Total   466,272    
Research facilities New Drug Development Support Center Ministry of Science, ICT and Future Planning 70,068 22,969 Evaluate new drug candidates and conduct joint research and development
High-tech Medical Equipment Development Support Center Ministry of Industry, Trade & Energy 10,887 Design product, support and develop the production of prototype
Lab Animal Center Health care 8,696 Offer laboratory animal system, support and manage laboratory animals
Clinical Drug Manufacturing Center Health care 8,955 Produce samples for clinical trials, support technology transfer
High-tech Clinical Trial Center Private 52,455 Unknown Small-scale clinical trial
Amenities Communication Center Daegu City 10,110 17,825 Offices, meeting rooms, accommodations, amenities and dormitories
Science Village Daegu City 2,298 1,839 Dormitories for researchers, sports facilities
Government institutions Korea Brain Research Institute DGIST 52,000 32,300 Research the big four brain research sectors, concentrate brain research capability, build infrastructure for brain research and play a hub role
Center for application of oriental medicine Korea Institute of Oriental Medicine 11,550 6,110 Develop natural product drug and convergence oriental medicine equipment
3D convergence technology support center Kyungpook National University 3,491 8,800 Develop 3D convergence technology, build integrated test/authorized equipment, support technology commercialization
Area for research institutions Joint research center of medical venture businesses Private 3,945 21,883 Research centers and support facilities for SMEs
Laboratory enterprises (sales completed) Private 22,966   Laboratories of medical companies
Area for private institutions Private 237,389   Research institutions, venture centers

■ Land by sectors

(Unit: ㎡, %)

Total Area High-tech Medical Cluster Other areas
Total Research Centers Research Facilities Amenities

■ Plan for the sales of research facilities

  • 289,369㎡(Total area for sale 466,272㎡, sale completed 176,903㎡) ※As of Jun. 30, 2014 Possible to parcel out the land into an optimal size (minimum 1,650㎡)
  • Sale price KRW 596,838/㎡ (KRW 1,973,017/3.3㎡) ※Reference price of plant land of industrial zone in Daegu: Seongseo Industrial Complex 3~5 million won/3.3㎡
  • Period: Jun. 29, 2012 ~
    ※ Application on a rolling basis
  • Land for Sales
    ㆍGeneral sale: Application on a rolling basis from Jun. 29, 2012
    ㆍSpecial supply: Attract excellent research institutions and laboratories
  • Tenants: universities, research institutions, laboratory enterprises, local and foreign preclinical trial institutions
    ※ The manufacturing industry cannot move into the complex. However, it is possible to produce medical supplies and equipment for clinical trials.
  • Requirements (Human resources and facility standard)
    ㆍHuman resources: three researchers who conduct only medical research and development and no other works including sales and business. (one researcher for a venture company in accordance with Article 2 of the Act on Special Measures for the Promotion of Venture Businesses)
    ㆍFacility standard: The tenant should be equipped with the following facilities to independently carry out medical research and development:
       - one or more laboratories
       - experiment equipment and research tools that researchers can use independently
       - subsidiary facilities including facilities for air purification and air conditioning and heating

■ Sales and move-in procedure

■ Incentives

  • Tax Support
    ㆍNational tax: Corporate tax, income tax - 100 percent exemption for the first three years and 50 percent reduction for the next two years.
    ㆍLocal tax: Acquisition tax exemption / property tax - 100 percent exemption for the first ten years and 50 percent reduction for the next 3 years.
    ㆍForeign-invested company: corporate tax, income tax - 100 percent exemption for maximum five years and 50 percent reduction for the next two years, acquisition tax exemption, property tax ? 100 percent exemption for the first 15 years.
  • Financial support
    ㆍSubsidies for the regional investment promotion: maximum KRW 6 billion for newly established companies and transferred companies
    ㆍSubsidies for location and investment: maximum KRW 1 billion
    ㆍSpecial subsidies for large-scale domestic and foreign investment companies: support a part of the total investment (partial support of site purchase cost, construction cost, facility and equipment cost)
    ㆍSubsidies for employment and training: no more than KRW 500,000 per person and within 6 months
    ㆍForeign-invested companies: Companies with foreign investment of more than 30 percent (Support site purchase cost, rent cost, construction cost and subsidies for employment and training)
    ※This may differ according to the type of tenant and the scope of investment. (Supported by relevant laws and the Daegu City Ordinance)
  • Special support
    ㆍSupport R&D budget for research and development of new drugs and high-tech medical equipment
    ※Support companies through national R&D budget for the high-tech medical complex and the fund for the establishment of Medi-city.
    ㆍCreate Medi-city funds (KRW 50 billion for the promotion of medical industry) and medical industry funds.
    ㆍSupport to foster tailored resources, utilize the excellent domestic and foreign resources and infrastructure and create a work environment.
  • Land purchase support
    ㆍPayment in installment for five years free-of-interest or offer discount (12.37 percent) for payment all at once.
    ※Research institutions of SMEs and venture companies support a part of the communication center (4,000㎡) / support sales for private institutions (under progress)
  • Special case of regulation
    ㆍMedical Service Act
       - Allow foreign medical personnel to conduct medical services at medical institutions within the complex for medical R&D.
    ㆍNational Health Insurance Act
       - Recognize as medical care when medical supplies, equipment and technology are used to patients for clinical trials. (Substantial reduction of clinical trial cost).
    ㆍPharmaceutical Affairs Act / Medical Appliances Act
       - Item permission is given to medical supplies and equipment that do not meet the standard of production facility.
       - International rules are applied to the permission and notification of importing medical supplies and equipment for research purposes, the manufacturing of medical supplies and equipment and the permission standard for import items.
    ㆍBioethics and Safety Act
       - A sub-committee of the National Bioethics Committee is established in the complex to separately deliberate the items concerning bioethics and safety.
       - The institutions in the complex utilizes the Institutional Bioethics Review Board
    ㆍImmigration Control Act
       - Extend the period of stay for foreign researchers (2→5 years).
    ㆍPatent Act
       - Preference examination for the R&D patent developed in the complex.
  • Administrative support
    ㆍProvide one-stop service of approval and permission from sales to move-in.
    ㆍDesignate a public servant who manages from consulting to research and development.